Has Cynthia Chase received payments from drug or device companies?

Yes. Drug and device makers reported $1,657 in general payments to Cynthia Chase across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cynthia Chase did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cynthia Chase come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cynthia Chase

Pediatrics · Las Vegas, NVNPI 1134425820

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Merck at 24.7% of the total. Reporting peaked in 2022 at $488 and has fallen 67.2% since, to $160 in 2025. Among pediatrics clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,657in general payments, 2019–2025

Across 77 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$409
Merz North America, Inc.$240
Kaleo, Inc.$190
GSK$169
Pfizer$151
Takeda Pharmaceuticals U.S.A., Inc.$64
plus $433 from 13 others

What the payments were for

Food & beverage$1,657100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	19	$409
Merz North America, Inc.	1	$240
Kaleo, Inc.	12	$190
GSK	10	$169
Pfizer	9	$151
Takeda Pharmaceuticals U.S.A., Inc.	4	$64
Cranial Technologies, Inc	4	$64
Seqirus USA Inc	2	$51
Viiv Healthcare Company	2	$51
Tris Pharma Inc	2	$47
Galderma Laboratories, L.p.	2	$43
Sobi, Inc	1	$35
Phadia US Inc.	2	$30
Sanofi Pasteur Inc.	2	$26
Nestle Healthcare Nutrition Inc.	1	$23
Ultragenyx Pharmaceutical Inc.	1	$17
Biogen	1	$16
Genentech USA, Inc.	1	$14
AstraZeneca	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$240
VAXNEUVANCE$111

How this compares

$1,657 in reported general payments places this provider in the 90th percentile of 327 pediatrics providers in Nevada.

See all pediatrics providers in Nevada →

Other pediatrics in Las Vegas

Carolina KoleticLas Vegas$80K
Ryan YoshikawaLas Vegas$10K
Trisha BrionesLas Vegas$7K
Adelaida ResuelloLas Vegas$5K
Kathleen ReardonLas Vegas$4K
Michael TenbyLas Vegas$3K
Jennifer BuitragoLas Vegas$3K
Maria Desquitado-TaboraLas Vegas$3K
Huynh Truong VuLas Vegas$2K
Arlene BayrederLas Vegas$2K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →